- /
- Supported exchanges
- / BE
- / BUWA.BE
BIO-RAD LAB-A (BUWA BE) stock market data APIs
BIO-RAD LAB-A Financial Data Overview
There is no Profile data available for BUWA.BE.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get BIO-RAD LAB-A data using free add-ons & libraries
Get BIO-RAD LAB-A Fundamental Data
BIO-RAD LAB-A Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIO-RAD LAB-A News
New
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity
Company Logo The blood collection tubes market presents opportunities through innovation in automated systems, advanced materials, and digital traceability to enhance workflow efficiency and complian...
Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid Expansion in the Venous Blood Collection Market Through 2032
Company Logo The venous blood collection market is poised for growth, driven by innovations in sampling technology and increasing demand due to chronic disease prevalence. Opportunities lie in automa...
A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Key Insights The projected fair value for Bio-Rad Laboratories is US$394 based on 2 Stage Free Cash Flow to Equity With US$325 share price, Bio-Rad Laboratories appears to be trading close to its est...
Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
Company Logo The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to US$ 10.63 billion by 2033, at a CAGR of 7.17%. Key growth dr...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.